Off-label use of orphan medicinal products: a Belgian qualitative study

BACKGROUND: Off-label use of (orphan) medicinal products for (rare) diseases is quite common but not underpinned by clinical studies to confirm efficacy and safety. No risk-analyses by regulatory agencies are carried out. The objective of this study was to map off-label use of orphan medicinal produ...

Descripción completa

Detalles Bibliográficos
Autores principales: Dooms, Marc, Cassiman, David, Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086036/
https://www.ncbi.nlm.nih.gov/pubmed/27793155
http://dx.doi.org/10.1186/s13023-016-0507-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086036/
https://www.ncbi.nlm.nih.gov/pubmed/27793155
http://dx.doi.org/10.1186/s13023-016-0507-y

Ejemplares similares